Added value for existing medication.

Hyloris boosts the potential of existing medication. The company creates new formulas, dosages and methods. This way they create extra value for patients and professionals.

Discover related investments

investment overview


Innovative window and door solutions.

Paul Thiers was a member and chairman of the Board of Deceuninck. Thinc.Capital invests in Deceunick as we believe Deceuninck is well placed to profit from the renovation wave.

Read more about Deceuninck

Impressive growth stories

read our news

Want to know more?

Contact thinc.capital